• Accueil >
  • Publications >
  • Trastuzumab emtansine in HER2-positive metastatic breast cancer: what is the best sequence?

Trastuzumab emtansine in HER2-positive metastatic breast cancer: what is the best sequence?

1 févr. 2018Chinese Clinical Oncology

DOI : 10.21037/cco.2017.10.08

Auteurs

Francesco Ricci, Christophe Le Tourneau